Objective To investigate the effects of vitamin D on synthesis and secretion of lubricin in chondrocytes at the cellular level. Methods Rat articular chondrocytes were stimulated by TNF-α. Normal and inflammatory chondrocytes were treated by different doses of vitamin D respectively. ELISA and Western Blot were used to detect the secretion of lubricin in the supernatant and the synthesis level in the cells. Results TNF-α significantly reduced the activity of both normal chondrocytes and chondrocytes in inflammatory state. TNF-α also significantly reduced the expression of lubricin in the cells and supernatant.1α,25(OH)2D3 increased the activity of both normal chondrocytes and chondrocytes in inflammatory state. 1α,25(OH)2D3 significantly elevated the secretion and expression of supernatant and intracellular lubricin only in chondrocytes stimulated by TNF-α in a dose-dependent manner, but not in normal chondrocytes. Conclusions Vitamin D can promote the secretion and expression of lubricin in inflammatory state chondrocytes, which may act as one of the mechanisms of vitamin D protecting the cartilage surface in osteoarthritis.
[2] Wieland HA, Michaelis M, Kirschbaum BJ, et al. Osteoarthritis - an untreatable disease?[J]. Nat Rev Drug Discov, 2005, 4(4): 331-344.
[3] Olson SA, Horne P, Furman B, et al. The role of cytokines in posttraumatic arthritis[J]. J Am Acad Orthop Surg, 2014, 22(1): 29-37.
[4] Greene GW, Banquy X, Lee DW, et al. Adaptive mechanically controlled lubrication mechanism found in articular joints[J]. Proc Natl Acad Sci U S A, 2011, 108(13): 5255-5259.
[5] Jones AR, Flannery CR. Bioregulation of lubricin expression by growth factors and cytokines[J]. Eur Cell Mater, 2007, 13: 40-45.
[6] Seror J, Zhu L, Goldberg R, et al. Supramolecular synergy in the boundary lubrication of synovial joints[J]. Nat Commun, 2015, 6: 6497.
[7] Jones AR, Gleghorn JP, Hughes CE, et al. Binding and localization of recombinant lubricin to articular cartilage surfaces[J]. J Orthop Res, 2007, 25(3): 283-292.
[8] Iqbal SM, Leonard C, Regmi SC, et al. Lubricin/proteoglycan 4 binds to and regulates the activity of Toll-like receptors in vitro[J]. Sci Rep, 2016, 6: 18910.
[9] Flannery CR. Novel therapies in OA[J]. Curr Drug Targets, 2010, 11(5): 614-619.
[11] Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice[J]. Endocr Rev, 2008, 29(6): 726-776.
[12] Prietl B, Treiber G, Pieber TR, et al. Vitamin D and immune function[J]. Nutrients, 2013, 5(7): 2502-2521.
[13] George J. Vitamin D supplementation and progression of knee osteoarthritis[J]. JAMA, 2016, 316(3): 347-348.
[14] Onuora S. Osteoarthritis: Vitamin D not effective for knee OA[J]. Nat Rev Rheumatol, 2016, 12(5): 252.
[15] Mabey T, Honsawek S. Role of vitamin D in osteoarthritis: molecular, cellular, and clinical perspectives[J]. Int J Endocrinol, 2015, 2015: 383918.
[16] Zhang FF, Driban JB, Lo GH, et al. Vitamin D deficiency is associated with progression of knee osteoarthritis[J]. J Nutr, 2014, 144(12): 2002-2008.
[17] Muraki S, Dennison E, Jameson K, et al. Association of vitamin D status with knee pain and radiographic knee osteoarthritis[J]. Osteoarthritis Cartilage, 2011, 19(11): 1301-1306.
[18] Rizzoli R, Stevenson JC, Bauer JM, et al. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)[J]. Maturitas, 2014, 79(1): 122-132.
[19] Tetlow LC, Woolley DE. Expression of vitamin D receptors and matrix metalloproteinases in osteoarthritic cartilage and human articular chondrocytes in vitro[J]. Osteoarthr Cartil, 2001, 9(5): 423-431.
[20] Li S, Niu G, Wu Y, et al. Vitamin D prevents articular cartilage erosion by regulating collagen II turnover through TGF-beta1 in ovariectomized rats[J]. Osteoarthr Cartil, 2016, 24(2): 345-353.
[21] Neu CP, Khalafi A, Komvopoulos K, et al. Mechanotransduction of bovine articular cartilage superficial zone protein by transforming growth factor beta signaling[J]. Arthritis Rheumat, 2007, 56(11): 3706-3714.
[22] Miyatake K, Iwasa K, Mcnary S M, et al. Modulation of superficial zone protein/lubricin/PRG4 by kartogenin and transforming growth factor-beta1 in surface zone chondrocytes in bovine articular cartilage[J]. Cartilage, 2016, 7(4): 388-397.
[24] Young AA, Mclennan S, Smith MM, et al. Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis[J]. Arthritis Res Ther, 2006, 8(2): R41.
[25] Jay GD, Fleming BC, Watkins BA, et al. Prevention of cartilage degeneration and restoration of chondroprotection by lubricin tribosupplementation in the rat following anterior cruciate ligament transection[J]. Arthr Rheumat, 2010, 62(8): 2382-2391.
[26] Lee SY, Niikura T, Reddi AH. Superficial zone protein (lubricin) in the different tissue compartments of the knee joint: modulation by transforming growth factor beta 1 and interleukin-1 beta[J]. Tissue Eng Part A, 2008, 14(11): 1799-808.
[27] Oestergaard S, Sondergaard BC, Hoegh-Andersen P, et al. Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation[J]. Arthr Rheumat, 2006, 54(8): 2441-2451.
[28] Richette P, Dumontier MF, Francois M, et al. Dual effects of 17beta-oestradiol on interleukin 1beta-induced proteoglycan degradation in chondrocytes[J]. Ann Rheum Dis, 2004, 63(2): 191-199.
[29] Arden NK, Cro S, Sheard S, et al. The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial[J]. Osteoarthr Cartil, 2016, 24(11): 1858-1866.